Showing 1-9 of 9 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models – NHPig | Universitätsklinikum der Ludwig-Maximilians-Universität München | Eckhard Wolf | Cures | 01-June-2025 to 31-May-2028 | $484,500.00 |
| Fr1da-Plus: Beta-cell autoantibody screening for early diagnosis of type 1 diabetes in childhood | Helmholtz Munich, Helmholtz Zentrum Muenchen Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Anette-Gabriele Ziegler | Cures | 01-August-2019 to 31-July-2025 | $1,387,500.00 |
| Building a time-resolved atlas for SC-islet differentiation to identify key drivers of beta cell development | Helmholtz Munich, Helmholtz Zentrum Muenchen Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Fabian Theis | Cures | 01-September-2024 to 31-December-2025 | $199,998.00 |
| Leveraging Generative AI to Improve Islet Potency in Cell Replacement Therapies for T1D | Helmholtz Munich, Helmholtz Zentrum Muenchen Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Fabian Theis | Cures | 01-September-2025 to 31-August-2028 | $749,999.00 |
| Immune-cloaking strategies for protection of stem cell derived beta cells in the human relevant pig model | Helmholtz Munich, Helmholtz Zentrum Muenchen Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Matthias Hebrok | Cures | 01-September-2023 to 31-August-2026 | $2,248,960.00 |
| Investigating granins as essential insulin granule components and their impact in type 1 diabetes | Helmholtz Munich, Helmholtz Zentrum Muenchen Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Teresa Rodriguez-Calvo | Cures | 01-September-2025 to 31-August-2028 | $638,296.00 |
| Proinsulin processing and presentation in human type 1 diabetes: a beta cell – T cell perspective | Helmholtz Munich, Helmholtz Zentrum Muenchen Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Teresa Rodriguez-Calvo | Cures | 01-July-2020 to 31-December-2025 | $749,795.28 |
| Characterization of T1D antibody combination therapies with a curative potential | Hannover Medical School | Anne Joerns | Cures | 01-April-2024 to 31-March-2027 | $770,000.00 |
| Multi-omics and glycemic trait-based decomposition of the heterogeneity of type 1 diabetes | Deutsche Diabetes-Forschungsgesellschaft e.V. | Robert Wagner | Cures | 01-February-2025 to 31-January-2027 | $591,522.00 |